Bioassays

Details for Australian Patent Application No. 2006318950 (hide)

Owner UCB Pharma S.A.

Inventors Finney, Helene Margaret; Lawson, Alastair David Griffiths

Agent Watermark

Pub. Number AU-A-2006318950

PCT Pub. Number WO2007/060406

Priority 0523954.6 24.11.05 GB

Filing date 21 November 2006

Wipo publication date 31 May 2007

International Classifications

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 5/16 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

17 July 2008 PCT application entered the National Phase

  PCT publication WO2007/060406 Priority application(s): WO2007/060406

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006318951-Methods of stabilizing unconsolidated subterranean formations

2006318948-Pyrido-,pyrazoand pyrimido-pyrimidine derivatives as mTOR inhibitors